Jacqueline Scanlan
Ufficiale delle Risorse Umane presso FMC CORPORATION
Patrimonio netto: 2 M $ in data 30/04/2024
Posizioni attive di Jacqueline Scanlan
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| FMC CORPORATION | Ufficiale delle Risorse Umane | 25/09/2023 | - |
Storia della carriera di Jacqueline Scanlan
Precedenti posizioni note di Jacqueline Scanlan
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| HAEMONETICS CORPORATION | Ufficiale delle Risorse Umane | 01/03/2017 | 11/06/2021 |
Novo Nordisk, Inc.
 Novo Nordisk, Inc. BiotechnologyHealth Technology Novo Nordisk, Inc. operates diabetes care company. It offers biopharmaceuticals, chronic weight management, human growth hormone therapy and hemophilla management services. The firm also provides rare bleeding disorders, growth hormone related disorders, and women's health. The company was founded in 1982 and is headquartered in Plainsboro, NJ. | Ufficiale delle Risorse Umane | 15/10/2014 | 01/10/2016 |
| AXALTA COATING SYSTEMS LTD. | Ufficiale delle Risorse Umane | 14/06/2021 | - |
| CAMPBELL SOUP COMPANY | Corporate Officer/Principal | - | - |
Formazione di Jacqueline Scanlan
| St. Joseph's University | Undergraduate Degree |
| University of Pennsylvania | Graduate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 8 |
Posizioni
| Human Resources Officer | 4 |
| Undergraduate Degree | 1 |
| Graduate Degree | 1 |
Settori
| Health Technology | 3 |
| Consumer Services | 3 |
| Process Industries | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 4 |
|---|---|
| HAEMONETICS CORPORATION | Health Technology |
| CAMPBELL SOUP COMPANY | Consumer Non-Durables |
| AXALTA COATING SYSTEMS LTD. | Process Industries |
| FMC CORPORATION | Process Industries |
| Aziende private | 1 |
|---|---|
Novo Nordisk, Inc.
Novo Nordisk, Inc. BiotechnologyHealth Technology Novo Nordisk, Inc. operates diabetes care company. It offers biopharmaceuticals, chronic weight management, human growth hormone therapy and hemophilla management services. The firm also provides rare bleeding disorders, growth hormone related disorders, and women's health. The company was founded in 1982 and is headquartered in Plainsboro, NJ. | Health Technology |
- Borsa valori
- Insiders
- Jacqueline Scanlan
- Esperienza
